4
Changes in Ownership
Mirum Pharmaceuticals, Inc. Filed Acc 0001240122-25-000007
Director sold 50,000 shares at $74.00 ($3,700,000)
- Director acquired 50,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
GREY MICHAEL G · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-01 | Exercise or conversion : show line 1 in the form 10b5-1 | +50,000 | $2.94 | $146,800 | 50,000 | D |
| 2025-12-01 | Sale : show line 2 in the form 10b5-1 | −50,000 | $74.00 | $3,700,000 | 0 | D |
| Open-market sales · 50,000 sh · avg $74.00 · $3,700,000 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-12-01 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (right to buy) | −50,000 | 231,176 | D |
Loading xslF345X05/form4-12022025_091224.xml…